Drug Profile
DTaP-poliovirus vaccine paediatric - GSK
Alternative Names: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Paediatric) - GSK; DTaP-IPV paediatric vaccine - GSK; Infanrix IPV; Infanrix-IPV; KinrixLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 24 Jun 2008 Registered for Diphtheria in USA (IM)
- 24 Jun 2008 Registered for Pertussis in USA (IM)
- 24 Jun 2008 Registered for Poliomyelitis in USA (IM)